Cargando…
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates
Human respiratory syncytial virus (RSV) and parainfluenza virus type 3 (HPIV3) are among the most common viral causes of childhood bronchiolitis and pneumonia worldwide, and lack effective antiviral drugs or vaccines. Recombinant (r) HPIV3 was modified to express the RSV fusion (F) glycoprotein, the...
Autores principales: | Liu, Xueqiao, Liang, Bo, Liu, Xiang, Amaro-Carambot, Emerito, Surman, Sonja, Kwong, Peter D., Graham, Barney S., Collins, Peter L., Munir, Shirin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012412/ https://www.ncbi.nlm.nih.gov/pubmed/32045432 http://dx.doi.org/10.1371/journal.pone.0228572 |
Ejemplares similares
-
The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome
por: Schomacker, Henrick, et al.
Publicado: (2012) -
Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates
por: Schaap-Nutt, Anne, et al.
Publicado: (2010) -
The alpha-1 subunit of the Na(+),K(+)-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells
por: Lingemann, Matthias, et al.
Publicado: (2019) -
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022) -
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
por: Nouën, Cyril Le, et al.
Publicado: (2022)